CN1193062C - Biological material using electrostatic attraction layer-layer self-assembled modified polyester material as surface with cell compatibility - Google Patents
Biological material using electrostatic attraction layer-layer self-assembled modified polyester material as surface with cell compatibility Download PDFInfo
- Publication number
- CN1193062C CN1193062C CN 02112499 CN02112499A CN1193062C CN 1193062 C CN1193062 C CN 1193062C CN 02112499 CN02112499 CN 02112499 CN 02112499 A CN02112499 A CN 02112499A CN 1193062 C CN1193062 C CN 1193062C
- Authority
- CN
- China
- Prior art keywords
- layer
- polyamine
- poly
- acid
- polymer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 229920000728 polyester Polymers 0.000 title claims abstract description 34
- 239000000463 material Substances 0.000 title claims abstract description 22
- 239000012620 biological material Substances 0.000 title claims abstract description 16
- 238000000034 method Methods 0.000 claims abstract description 30
- 229920000642 polymer Polymers 0.000 claims abstract description 18
- 239000002861 polymer material Substances 0.000 claims abstract description 13
- 239000002253 acid Substances 0.000 claims abstract description 12
- 229920000447 polyanionic polymer Polymers 0.000 claims abstract description 11
- 125000003368 amide group Chemical group 0.000 claims abstract description 6
- 229920000768 polyamine Polymers 0.000 claims description 21
- 229920001467 poly(styrenesulfonates) Polymers 0.000 claims description 16
- 229920001432 poly(L-lactide) Polymers 0.000 claims description 15
- 229920001661 Chitosan Polymers 0.000 claims description 13
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 11
- 239000012153 distilled water Substances 0.000 claims description 11
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 11
- 239000000203 mixture Substances 0.000 claims description 10
- 102000008186 Collagen Human genes 0.000 claims description 9
- 108010035532 Collagen Proteins 0.000 claims description 9
- 229920001436 collagen Polymers 0.000 claims description 9
- -1 nonyl amines Chemical class 0.000 claims description 9
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 claims description 8
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 claims description 8
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 8
- 230000004071 biological effect Effects 0.000 claims description 8
- 150000002500 ions Chemical class 0.000 claims description 8
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 claims description 8
- 238000006243 chemical reaction Methods 0.000 claims description 7
- 230000000975 bioactive effect Effects 0.000 claims description 6
- 229920000669 heparin Polymers 0.000 claims description 6
- 229960002897 heparin Drugs 0.000 claims description 6
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims description 6
- 239000000126 substance Substances 0.000 claims description 6
- 238000001291 vacuum drying Methods 0.000 claims description 6
- 229920002292 Nylon 6 Polymers 0.000 claims description 4
- 238000010521 absorption reaction Methods 0.000 claims description 4
- VHRGRCVQAFMJIZ-UHFFFAOYSA-N cadaverine Chemical compound NCCCCCN VHRGRCVQAFMJIZ-UHFFFAOYSA-N 0.000 claims description 4
- FEMOMIGRRWSMCU-UHFFFAOYSA-N ninhydrin Chemical compound C1=CC=C2C(=O)C(O)(O)C(=O)C2=C1 FEMOMIGRRWSMCU-UHFFFAOYSA-N 0.000 claims description 4
- 239000003960 organic solvent Substances 0.000 claims description 4
- 150000003384 small molecules Chemical group 0.000 claims description 4
- 229920002554 vinyl polymer Polymers 0.000 claims description 4
- VUDQSRFCCHQIIU-UHFFFAOYSA-N 1-(3,5-dichloro-2,6-dihydroxy-4-methoxyphenyl)hexan-1-one Chemical compound CCCCCC(=O)C1=C(O)C(Cl)=C(OC)C(Cl)=C1O VUDQSRFCCHQIIU-UHFFFAOYSA-N 0.000 claims description 3
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 claims description 3
- SQDAZGGFXASXDW-UHFFFAOYSA-N 5-bromo-2-(trifluoromethoxy)pyridine Chemical compound FC(F)(F)OC1=CC=C(Br)C=N1 SQDAZGGFXASXDW-UHFFFAOYSA-N 0.000 claims description 3
- 229920001287 Chondroitin sulfate Polymers 0.000 claims description 3
- 101000942967 Homo sapiens Leukemia inhibitory factor Proteins 0.000 claims description 3
- 108090000723 Insulin-Like Growth Factor I Proteins 0.000 claims description 3
- 102100032352 Leukemia inhibitory factor Human genes 0.000 claims description 3
- 229920001244 Poly(D,L-lactide) Polymers 0.000 claims description 3
- 102000013275 Somatomedins Human genes 0.000 claims description 3
- 125000000129 anionic group Chemical group 0.000 claims description 3
- 125000002091 cationic group Chemical group 0.000 claims description 3
- 229940059329 chondroitin sulfate Drugs 0.000 claims description 3
- 239000008367 deionised water Substances 0.000 claims description 3
- 229910021641 deionized water Inorganic materials 0.000 claims description 3
- 235000019441 ethanol Nutrition 0.000 claims description 3
- 229920001495 poly(sodium acrylate) polymer Polymers 0.000 claims description 3
- 235000010413 sodium alginate Nutrition 0.000 claims description 3
- 229940005550 sodium alginate Drugs 0.000 claims description 3
- 239000000661 sodium alginate Substances 0.000 claims description 3
- NNMHYFLPFNGQFZ-UHFFFAOYSA-M sodium polyacrylate Chemical compound [Na+].[O-]C(=O)C=C NNMHYFLPFNGQFZ-UHFFFAOYSA-M 0.000 claims description 3
- 229940006186 sodium polystyrene sulfonate Drugs 0.000 claims description 3
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 claims description 2
- NIXOWILDQLNWCW-UHFFFAOYSA-N 2-Propenoic acid Natural products OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 claims description 2
- MHZGKXUYDGKKIU-UHFFFAOYSA-N Decylamine Chemical class CCCCCCCCCCN MHZGKXUYDGKKIU-UHFFFAOYSA-N 0.000 claims description 2
- XTHFKEDIFFGKHM-UHFFFAOYSA-N Dimethoxyethane Chemical compound COCCOC XTHFKEDIFFGKHM-UHFFFAOYSA-N 0.000 claims description 2
- KGWDUNBJIMUFAP-KVVVOXFISA-N Ethanolamine Oleate Chemical compound NCCO.CCCCCCCC\C=C/CCCCCCCC(O)=O KGWDUNBJIMUFAP-KVVVOXFISA-N 0.000 claims description 2
- 229920002971 Heparan sulfate Polymers 0.000 claims description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 claims description 2
- 229920000954 Polyglycolide Polymers 0.000 claims description 2
- 108010039918 Polylysine Proteins 0.000 claims description 2
- NSOXQYCFHDMMGV-UHFFFAOYSA-N Tetrakis(2-hydroxypropyl)ethylenediamine Chemical compound CC(O)CN(CC(C)O)CCN(CC(C)O)CC(C)O NSOXQYCFHDMMGV-UHFFFAOYSA-N 0.000 claims description 2
- QVYARBLCAHCSFJ-UHFFFAOYSA-N butane-1,1-diamine Chemical compound CCCC(N)N QVYARBLCAHCSFJ-UHFFFAOYSA-N 0.000 claims description 2
- SYECJBOWSGTPLU-UHFFFAOYSA-N hexane-1,1-diamine Chemical compound CCCCCC(N)N SYECJBOWSGTPLU-UHFFFAOYSA-N 0.000 claims description 2
- 150000002466 imines Chemical class 0.000 claims description 2
- IOQPZZOEVPZRBK-UHFFFAOYSA-N octan-1-amine Chemical compound CCCCCCCCN IOQPZZOEVPZRBK-UHFFFAOYSA-N 0.000 claims description 2
- 230000020477 pH reduction Effects 0.000 claims description 2
- 229920000118 poly(D-lactic acid) Polymers 0.000 claims description 2
- 229920001610 polycaprolactone Polymers 0.000 claims description 2
- 239000004632 polycaprolactone Substances 0.000 claims description 2
- 229920000139 polyethylene terephthalate Polymers 0.000 claims description 2
- 239000005020 polyethylene terephthalate Substances 0.000 claims description 2
- 239000004633 polyglycolic acid Substances 0.000 claims description 2
- 229920000656 polylysine Polymers 0.000 claims description 2
- 229920006254 polymer film Polymers 0.000 claims description 2
- AOHJOMMDDJHIJH-UHFFFAOYSA-N propylenediamine Chemical compound CC(N)CN AOHJOMMDDJHIJH-UHFFFAOYSA-N 0.000 claims description 2
- 238000001338 self-assembly Methods 0.000 abstract description 7
- 238000012986 modification Methods 0.000 abstract description 4
- 230000004048 modification Effects 0.000 abstract description 4
- 229920000867 polyelectrolyte Polymers 0.000 abstract description 4
- 230000002349 favourable effect Effects 0.000 abstract description 2
- 239000010410 layer Substances 0.000 abstract 3
- 150000001412 amines Chemical class 0.000 abstract 1
- 230000005611 electricity Effects 0.000 abstract 1
- 239000002365 multiple layer Substances 0.000 abstract 1
- 239000002356 single layer Substances 0.000 abstract 1
- 229960002796 polystyrene sulfonate Drugs 0.000 description 13
- 239000011970 polystyrene sulfonate Substances 0.000 description 13
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 12
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 8
- 210000003725 endotheliocyte Anatomy 0.000 description 8
- 210000003954 umbilical cord Anatomy 0.000 description 8
- JVTAAEKCZFNVCJ-REOHCLBHSA-N L-lactic acid Chemical compound C[C@H](O)C(O)=O JVTAAEKCZFNVCJ-REOHCLBHSA-N 0.000 description 6
- 210000004027 cell Anatomy 0.000 description 5
- 229910052757 nitrogen Inorganic materials 0.000 description 5
- 230000035755 proliferation Effects 0.000 description 5
- 239000008186 active pharmaceutical agent Substances 0.000 description 4
- 210000002889 endothelial cell Anatomy 0.000 description 4
- 230000012010 growth Effects 0.000 description 4
- 210000000056 organ Anatomy 0.000 description 4
- 229920000058 polyacrylate Polymers 0.000 description 4
- 239000004793 Polystyrene Substances 0.000 description 3
- 238000007098 aminolysis reaction Methods 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 229920002223 polystyrene Polymers 0.000 description 3
- 102000012422 Collagen Type I Human genes 0.000 description 2
- 108010022452 Collagen Type I Proteins 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- 230000001464 adherent effect Effects 0.000 description 2
- 244000309466 calf Species 0.000 description 2
- 238000005266 casting Methods 0.000 description 2
- 230000021164 cell adhesion Effects 0.000 description 2
- 230000010261 cell growth Effects 0.000 description 2
- 238000001976 enzyme digestion Methods 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 239000012528 membrane Substances 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- 238000002791 soaking Methods 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- JHUUPUMBZGWODW-UHFFFAOYSA-N 3,6-dihydro-1,2-dioxine Chemical compound C1OOCC=C1 JHUUPUMBZGWODW-UHFFFAOYSA-N 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 238000006065 biodegradation reaction Methods 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 238000005530 etching Methods 0.000 description 1
- 238000011010 flushing procedure Methods 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 238000007654 immersion Methods 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 238000002715 modification method Methods 0.000 description 1
- 231100000956 nontoxicity Toxicity 0.000 description 1
- 238000011017 operating method Methods 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 238000005191 phase separation Methods 0.000 description 1
- 229920000747 poly(lactic acid) Polymers 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- MNCGMVDMOKPCSQ-UHFFFAOYSA-M sodium;2-phenylethenesulfonate Chemical compound [Na+].[O-]S(=O)(=O)C=CC1=CC=CC=C1 MNCGMVDMOKPCSQ-UHFFFAOYSA-M 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 238000009736 wetting Methods 0.000 description 1
Images
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y30/00—Nanotechnology for materials or surface science, e.g. nanocomposites
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
Landscapes
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Nanotechnology (AREA)
- Crystallography & Structural Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Medical Informatics (AREA)
- Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Pharmacology & Pharmacy (AREA)
- Biophysics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Physics & Mathematics (AREA)
- Composite Materials (AREA)
- Condensed Matter Physics & Semiconductors (AREA)
- General Physics & Mathematics (AREA)
- Materials Engineering (AREA)
- Materials For Medical Uses (AREA)
- Laminated Bodies (AREA)
Abstract
The present invention discloses a method of modifying a polymer material into a biological material with cell compatibility on the surface by electrostatic attraction layer-layer self-assembly. In the method, dualistic amine ammonolyzes the surface of a polyester polymer to obtain a polymer with free amido on the surface first; then the polymer is acidified by acid to make the surface of the polymer have positive electricity; different single layer or multiple-layer polyanions and polycations with bioactivity are alternately assembled on the surface of the polymer by an electrostatic attraction layer-layer self-assembly method; the polyelectrolyte with bioactivity can still retain the original bioactivity thereof after layer-layer self-assembly, and a planar film with cell compatibility on the surface, a three-dimensional multiporous support material and a product of the three-dimensional multiporous support material are obtained. The method of the present invention has the advantages of simple operation technology and high repetitiveness; the method of the present invention has a favorable application prospect for various biologic medical device in a complicated three-dimensional structure and the surface modification of support materials in multiporous tissue engineering.
Description
Technical field
The present invention relates to modified polyester material and have the method for cell compatible biological material for the surface.
Background technology
Polymer biomaterial is because of having good physics and chemical property, and the application in organizational project more and more widely.But because the special applied environment of this class material---need directly to contact with the body fluid of human body, organ, tissue etc., therefore preparing polymer biomaterial that a kind of surface has good biocompatibility becomes in the organizational project development very one of approach of key.
The polyester biomaterial not only has good physical and mechanical properties, nontoxicity, easy processing forming, but also has the peculiar biodegradable of tissue engineering material, therefore more and more is subjected to people's attention.With lactic acid or oxyacetic acid is the polyester polymer of skeleton unit, and licensed polymkeric substance as biological tissue's cultivation has developed into the most widely and used owing to meet clinical service requirements.But do not pass through the polyester polymer of modification because itself hydrophobicity and surface inertness cause providing the growth of a close friend's interface with effective promotion tissue and organ; The local acidity that the degraded back forms also can cause peripheral organs and tissue to produce serious inflammatory reaction.Though have the multiple surface modification method that improves its surface property at present, all there is the operating procedure complexity, the modification of surfaces poor stability does not especially fit into problems such as the timbering material of porous build complexity and goods.
Summary of the invention
The purpose of this invention is to provide a kind of simple to operately, is the method that the surface has cell compatible biological material with electrostatic attraction layer-layer self-assembled modified polyester material.
Method of the present invention may further comprise the steps:
1) the dissolving polyamine prepares the polyamine solution that concentration is 0.001~1g/ml in organic solvent;
2) the polyester polymer material is immersed in the polyamine solution, under 0~100 ℃ of temperature, reacted 0.1~10 hour;
3) the polyester polymer material is taken out polyamine solution, clean with deionized water or soaked in absolute ethyl alcohol, vacuum-drying is to constant weight;
4) use the indicator triketohydrindene hydrate to detect the amido of polyester polymer material surface;
5) concentration being immersed with the polymer materials of free amino in the surface is in the acid solution of 0.0024~0.12mol/L, at room temperature carries out acidification reaction 1~60 minute, and reaction finishes, and takes out and water is rinsed well;
6) polyester polymer with step 5) gained surface positively charged at first immerses in the bioactive poly anionic water solution that concentration is 0.001~1000mg/ml, absorption one deck negatively charged ion, and negative charge is with on the surface; With immersing again behind the tri-distilled water flush away free negatively charged ion in the bioactive poly cationic acid solution that concentration is 0.001~1000mg/ml, wash with acid earlier behind absorption one deck positively charged ion, use tri-distilled water flush away free positively charged ion again, at this moment positive charge has been with on the surface again, repeat above-mentioned steps, biological activity zwitterion alternate group is contained on the polyester polymer material.
7) after reaction finishes, take out and rinse well with acid or water, vacuum-drying is to constant weight under the room temperature.
Among the present invention, polyamine can be small molecules polyamine and polycaprolactam polyamine, the small molecules polyamine comprises a kind of or its mixture of quadrol, propylene diamine, butanediamine, pentamethylene diamine, hexanediamine, two n-octyl amine, two positive nonyl amines, two n-Decylamines, and polycaprolactam polyamine comprises a kind of or its mixture in polyvinyl imines, the PAH.
Among the present invention, the organic solvent that is used for dissolving polyamine includes, but are not limited to a kind of or its mixture of ethanol, thanomin, n-propyl alcohol, Virahol, glycol dimethyl ether, dimethyl sulfoxide (DMSO).
Described polymer materials, normally polyester polymer film and porous support.Polyester polymer is preferred: polycaprolactone, poly-(L-lactic acid), poly-(D-lactic acid), unformed poly-(D, L-lactic acid) (PDLLA), the multipolymer of a kind of and these polymkeric substance in PAUR, polyethylene terephthalate, polyglycolic acid, poly-(D, the L-lactic acid-be total to-oxyacetic acid).
The molecular weight of employed polyester polymer can consider, is 10000~1000000 polyester polymer but preferably use molecular weight ranges.
Porous support is meant the support that the inside hole by methods such as pore-creating agent method, phase separation method, weave, the freeze-dried method of emulsion, track etching method, speed forming method or nonwoven method preparations is interconnected.
Among the present invention, the biological activity polyanion is optional with a kind of or its mixture in Sodium styrene sulfonate (PSS), T 500 (DS), chondroitin sulfate (CSAS), sodium alginate (NaAlg), sodium polyacrylate (PAA), polymethyl acrylic acid, heparin, the heparin sulfate; Polycation can be selected a kind of or its mixture in collagen (Collagen), chitosan (Chitosan), poly-lysine, polyvinyl inferior amine salt hydrochlorate (PEI), the PAH hydrochloride (PAH) for use.The also optional usefulness of above-mentioned polyanion or polycation has various albumen, somatomedin and the differentiation inducing factor of both sexes charge property, these albumen, somatomedin and differentiation inducing factor can obtain different charged character by regulating the pH value: positively charged under the iso-electric point, and electronegative on the iso-electric point.
In the inventive method step 6), the preferred 0.1~50mg/ml of concentration of bioactive poly anionic water solution and bioactive poly cationic acid solution.
The present invention adopts polyamine aminolysis polyester polymer surface at first to obtain the polymkeric substance of surface band free amino, make the polymer surfaces positively charged with acidifying again, then it is alternately immersed in the solution of polyanion and polycation, utilize the method for electrostatic attraction layer-layer self-assembly by the electrostatic attraction effect of polyanion and polycation, alternately assemble the different polyanions and the polycation of single or multiple lift biologically active on its surface, these biological activity polyelectrolyte still keep its original biological activity after layer assembly, obtain the surface and have the planar film of cell compatibility and three-dimensional porous timbering material and goods thereof.These free aminos not only effectively provide further and biological activity polyelectrolyte reactive activity site, and the local acidity that produces in biodegradation process with polymkeric substance in the amido energy appropriateness after its degraded, be expected to alleviate the organ and tissue inflammation on every side that cause because of local acidity.Behind the electrostatic attraction self-assembly biological activity polyelectrolyte, the cell compatibility that more can further improve material has the biological activity of specific function with other.Technology of the present invention is simple, and the reaction conditions gentleness is easy to operate, and favorable reproducibility is applied widely, environmental friendliness.Be applicable to the finishing of material surface, porous support materials and macroscopical goods thereof of multiple complex shape.In the finishing of multiple biomedical devices with complex shape structure and multi-porous tissue engineering supporting material, have a good application prospect.
Description of drawings
Fig. 1 be on poly-(L-lactic acid) film of aminolysis after the self-assembly of PSS/ chitosan multilayer hydrodynamic(al) attitude contact angle (advancing angle) with the changing conditions of the assembling number of plies.The advancing angle of wherein unmodified poly-(L-lactic acid) is 85.3 degree.
Fig. 2 is adhesion rate, activity and the proliferation rate after people's umbilical cord endotheliocyte was grown respectively 12 hours and 4 days thereon before and after poly-(L-lactic acid) membrane surface modification, wherein a is tissue culturing polystyrene (TCPS), b is unmodified poly-(L-lactic acid) film, c is assembling one deck PSS poly-(L-lactic acid), d is poly-(L-lactic acid) film of assembling pair of lamina PSS/ chitosan (skin is a chitosan), e is poly-(the L-lactic acid) of assembling three double-deck PSS/ chitosans (skin is a chitosan), and f is poly-(L-lactic acid) film of assembling five double-deck PSS/ chitosans (skin is a chitosan).
After Fig. 3 is poly-(L-lactic acid) film surface-assembled individual layer PSS, the electromicroscopic photograph of people's umbilical cord endothelial cell growth after 4 days, wherein Fig. 3 a magnification is 1000 times, can clearly see the pattern of endotheliocyte adherent growth; Fig. 3 b magnification is 180 times.
After Fig. 4 is poly-(L-lactic acid) film surface-assembled three double shells glycan (outer is chitosan), the electromicroscopic photograph of people's umbilical cord endothelial cell growth after 4 days, wherein Fig. 4 a magnification is 472 times, can clearly see the situation of endotheliocyte adherent growth and intercellular contact; Fig. 4 b magnification is 180 times.
After Fig. 5 is different polyanions of PAUR film surface-assembled and collagen, the changing conditions of hydrodynamic(al) attitude contact angle.The advancing angle of blank PAUR film is 80 degree.
Fig. 6 is different polyanions of PAUR film surface-assembled and collagen (pair of lamina, outer the is collagen) adhesion rate that descendant's umbilical cord endotheliocyte was grown respectively 12 hours thereon, and a is a heparin among the figure, b is CSAS, and c is PAA, and d is DS, e is NaAlg, and f is PSS.
Fig. 7 is different polyanions of PAUR film surface-assembled and the proliferation rate of collagen (pair of lamina, outer is collagen) after descendant's umbilical cord endotheliocyte was grown respectively 4 days thereon, and a is a heparin among the figure, and b is CSAS, and c is PAA, and d is DS, and e is NaAlg, and f is PSS.
Fig. 8 is adhesion rate and the proliferation rate of growth after 4 days that the different double-deck PSS/PEI of PAUR film surface-assembled (the outer PEI of being) descendant's umbilical cord endotheliocyte was grown respectively 12 hours thereon.
Embodiment
Following example further specifies the present invention.
Example 1
To gather (L-lactic acid) and be dissolved in 1, and in the 4-dioxane (the poly(lactic acid) weight percent content is 3%), and water and cast from casting film-forming in the film forming mould.To gather (L-lactic acid) film immersion concentration is 1 of 0.06g/mL, and in 6-hexanediamine/n-propyl alcohol solution, 50 ℃ were reacted 8 minutes down, used the deionized water soaking and washing, dried under the vacuum.Getting the small pieces film is in the ninhydrin solution of 1.0mol/L in concentration, shows bluish voilet detection film surface and has free amido (NH
2).
Poly-(L-lactic acid) film of above-mentioned surface band free amino was immersed in the hydrochloric acid that concentration is 0.012mol/L acidifying 15 minutes, take out and with after the tri-distilled water rinsing, immerse in 1.0mg/ml sodium polystyrene sulfonate (PSS) solution and soaked 20 minutes, totally and with nitrogen dry up with the tri-distilled water rinsing, immerse again in the 1.0mg/ml chitosan acetic acid solution and soaked 15 minutes, with the flushing of 1% acetic acid solution, totally and with nitrogen dry up with the tri-distilled water rinsing more earlier.Repeat poly-(L-lactic acid) modified membrane that above-mentioned steps can prepare the multilayer assembling.Poly-(L-lactic acid) film is after the self-assembly of PSS/ chitosan layer upon layer electrostatic, and wetting ability obviously improves, and is alternately variation clocklike, the results are shown in Figure 1.This has also proved the generation of layer upon layer electrostatic self assembling process simultaneously.
With the type i collagen enzyme digestion of human umbilical cord's venous endothelial cell is separated, and plant in bottom tiling and have in 96 hole tissue culture polystyrene (TCPS) culture plates of polymeric film, nutrient solution is PRMI1640 and calf serum, 200 μ l are inoculated in every hole, culture plate is placed 37 ℃, 5%CO
2In the incubator, change liquid every other day, measure cell adhesion rate (12 hours) and the proliferation rate of cultivation after 4 days.Poly-(L-lactic acid) film obviously improves the consistency of endotheliocyte after layer upon layer electrostatic is self-assembled modified, the results are shown in Figure 2,3,4.
Example 2
PAUR is dissolved in N, in the dinethylformamide, makes polymer solution concentration reach 0.13g/mL, with this solution-cast casting film-forming in becoming film die.It is 1 of 0.06g/ml that the PAUR film is immersed concentration, and in 6-hexanediamine/n-propyl alcohol solution, 37 ℃ were reacted 5 minutes down, used the tri-distilled water soaking and washing, and vacuum-drying is to constant weight.Get the aminolysis PAUR of 2 cm long and 1 centimetre wide, in concentration is to soak in triketohydrindene hydrate/ethanol solution of 1.0mol/L to take out in 1 minute, 80 ℃ of heating down, the film surface presents tangible bluish voilet, shows to have amido (NH freely on this film surface
2).The PAUR film of above-mentioned surface band free amino was immersed in the hydrochloric acid that concentration is 0.012mol/l acidifying 15 minutes, take out and with after the tri-distilled water rinsing respectively at heparin (1.0mg/mL Heparin), chondroitin sulfate (1.0mg/mL CSAS), sodium polyacrylate (1.0mg/mL, PAA), sodium alginate (1.0mg/mL, NaAlg), T 500 (1.0mg/m second DS), sodium polystyrene sulfonate (1.0mg/mL, PSS) soaked 20 minutes in, totally and with nitrogen dry up, immersed concentration more respectively and be in the PEI acetic acid solution that 0.1% collagen acetic acid solution or concentration is 1.0mg/ml 20 minutes with the tri-distilled water rinsing., totally and with nitrogen dry up with the tri-distilled water rinsing more earlier, put into vacuum drying oven and dry with 1.0% acetate rinsing.Generation with fluorescent mark and hydrodynamic(al) attitude contact angle test (the results are shown in Figure 5) provable above-mentioned electrostatic attraction self assembling process.
With the type i collagen enzyme digestion of human umbilical cord's venous endothelial cell is separated, and plant in bottom tiling and have in 96 hole tissue culture polystyrene (TCPS) culture plates of polymeric film, nutrient solution is PRMI1640 and calf serum, 200 μ l are inoculated in every hole, culture plate is placed 37 ℃, 5%CO
2In the incubator, change liquid every other day, measure cell adhesion rate (12h) and the proliferation rate of cultivation after 4 days.The PAUR film obviously improves the consistency of endotheliocyte after layer upon layer electrostatic is self-assembled modified, the results are shown in Figure 6,7,8.
Claims (8)
1. be the method that the surface has cell compatible biological material with electrostatic attraction layer-layer self-assembled modified polyester material, this method comprises the following steps:
1) the dissolving polyamine prepares the polyamine solution that concentration is 0.001~1g/mL in organic solvent;
2) the polyester polymer material is immersed in the polyamine solution, under 0~100 ℃ of temperature, reacted 0.1~10 hour;
3) the polyester polymer material is taken out polyamine solution, clean with deionized water or soaked in absolute ethyl alcohol, vacuum-drying is to constant weight;
4) use the indicator triketohydrindene hydrate to detect the amido of polyester polymer material surface;
5) concentration being immersed with the polymer materials of free amino in the surface is in the hydrochloric acid soln of 0.0024~0.12mol/L, at room temperature carries out acidification reaction 1~60 minute, and reaction finishes, and takes out and water is rinsed well;
6) polyester polymer with step 5) gained surface positively charged at first immerses in the bioactive poly anionic water solution that concentration is 1.0mg/ml, absorption one deck negatively charged ion, and negative charge is with on the surface; With immersing again behind the tri-distilled water flush away free negatively charged ion in the bioactive poly cationic acid solution that concentration is 1.0mg/ml, wash with acid earlier behind absorption one deck positively charged ion, use tri-distilled water flush away free positively charged ion again, at this moment positive charge has been with on the surface again, repeat above-mentioned steps, biological activity zwitterion alternate group is contained on the polyester polymer material;
7) after reaction finishes, take out and rinse well with acid or water, vacuum-drying is to constant weight under the room temperature.
2. modified polyester material according to claim 1 has the method for cell compatible biological material for the surface, it is characterized in that said polyamine is small molecules polyamine or polycaprolactam polyamine, the small molecules polyamine comprises a kind of or its mixture of quadrol, propylene diamine, butanediamine, pentamethylene diamine, hexanediamine, two n-octyl amine, two positive nonyl amines, two n-Decylamines, and polycaprolactam polyamine comprises a kind of or its mixture in polyvinyl imines, the PAH.
3. modified polyester material according to claim 1 is for the surface has the method for cell compatible biological material, and the organic solvent that it is characterized in that being used for dissolving polyamine is a kind of or its mixture of ethanol, thanomin, n-propyl alcohol, Virahol, glycol dimethyl ether, dimethyl sulfoxide (DMSO).
4. modified polyester material according to claim 1 is characterized in that for the surface has the method for cell compatible biological material said polyester polymer material is polyester polymer film or porous support.
5. has the method for cell compatible biological material according to claim 1 or 4 described modified polyester materials for the surface, it is characterized in that said polyester polymer is polycaprolactone, poly-(L-lactic acid), poly-(D-lactic acid), unformed poly-(D, L-lactic acid), the multipolymer of a kind of or these polymkeric substance in PAUR, polyethylene terephthalate, polyglycolic acid, poly-(D, the L-lactic acid-be total to-oxyacetic acid).
6. modified polyester material according to claim 1 is characterized in that said polyanion is: a kind of or its mixture in sodium polystyrene sulfonate, T 500, chondroitin sulfate, sodium alginate, sodium polyacrylate, polymethyl acrylic acid, heparin, the heparin sulfate for the surface has the method for cell compatible biological material.
7. modified polyester material according to claim 1 is characterized in that said polycation has: a kind of or its mixture in collagen, chitosan, poly-lysine, polyvinyl inferior amine salt hydrochlorate, the PAH hydrochloride for the surface has the method for cell compatible biological material.
8. modified polyester material according to claim 1 is characterized in that for the surface has the method for cell compatible biological material said polyanion and polycation are albumen, somatomedin and the differentiation inducing factor with both sexes charge property.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 02112499 CN1193062C (en) | 2002-07-10 | 2002-07-10 | Biological material using electrostatic attraction layer-layer self-assembled modified polyester material as surface with cell compatibility |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 02112499 CN1193062C (en) | 2002-07-10 | 2002-07-10 | Biological material using electrostatic attraction layer-layer self-assembled modified polyester material as surface with cell compatibility |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1394901A CN1394901A (en) | 2003-02-05 |
CN1193062C true CN1193062C (en) | 2005-03-16 |
Family
ID=4742057
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN 02112499 Expired - Fee Related CN1193062C (en) | 2002-07-10 | 2002-07-10 | Biological material using electrostatic attraction layer-layer self-assembled modified polyester material as surface with cell compatibility |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1193062C (en) |
Families Citing this family (37)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN100453124C (en) * | 2006-04-28 | 2009-01-21 | 武汉理工大学 | Porous, laminated, tri-dimensional multiple-grade structure tissue stent material and its preparation method |
CN100415508C (en) * | 2006-05-30 | 2008-09-03 | 浙江大学 | Method for preparing high obstruction self assembling multilayer composite film |
CN100463713C (en) * | 2006-10-13 | 2009-02-25 | 东南大学 | Multilayer hollow Nano fiber in use for cell culture, and preparation method |
CN101006944B (en) * | 2007-01-31 | 2010-06-09 | 浙江大学 | A method for assembling RGD on the surface of porous pure titanium dental implant |
CN101745151B (en) * | 2009-12-31 | 2014-03-05 | 重庆大学 | Preparation method of gene-activated poly-lactic acid material for treating liver diseases |
CN101886337B (en) * | 2010-06-09 | 2012-01-04 | 南京工业大学 | Method for preparing antibacterial fiber |
CN102285183B (en) * | 2011-04-28 | 2013-08-07 | 吉林大学 | Polymer double-layer self-supporting film and application in preparation of actuator |
CN102441192B (en) * | 2011-09-30 | 2014-08-27 | 上海交通大学 | Gene-releasing type stent and preparation method thereof |
CN102580641B (en) * | 2012-03-01 | 2014-03-05 | 天津大学 | Method for producing natural polysaccharide-base nanocapsules |
CN102634792A (en) * | 2012-04-09 | 2012-08-15 | 天津大学 | Layer-by-layer electrostatic self-assembling method based on dopamine-modified polyelectrolyte and application |
CN102813963A (en) * | 2012-09-10 | 2012-12-12 | 高长有 | Method for fixing functional molecules on biomedical material surface with dopamine serving as bridging |
CN102950102B (en) * | 2012-11-09 | 2015-02-11 | 西南交通大学 | Preparation method of multi-growth-factor slow release coating of titanium and titanium alloy surface |
CN102940909B (en) * | 2012-12-03 | 2015-04-01 | 中国科学院苏州纳米技术与纳米仿生研究所 | Method for modifying tissue engineering scaffold |
CN102977391B (en) * | 2012-12-03 | 2014-04-16 | 中国科学院苏州纳米技术与纳米仿生研究所 | Method for quantitatively loading growth factors on tissue engineering scaffold, and applications thereof |
CN103100114B (en) * | 2013-01-23 | 2014-05-21 | 西南交通大学 | Preparation method of medical metal surface slow-released growth factor coating |
CN104056302B (en) * | 2013-03-18 | 2016-12-28 | 杭州启迪生物科技有限公司 | A kind of for tissue engineering bracket material building bone graft and preparation method thereof |
CN103191467B (en) * | 2013-04-07 | 2014-07-02 | 西南交通大学 | Preparation method for antibacterial coat for fixing various cell growth factors on medical metal |
US9895665B2 (en) * | 2014-02-21 | 2018-02-20 | Takara Bio Usa, Inc. | Spin columns comprising poly(acid) membrane separation matrices, and methods of making and using the same |
CN105199125A (en) * | 2014-06-09 | 2015-12-30 | 上海微创医疗器械(集团)有限公司 | Anticoagulation biological material and preparing method thereof |
US9782727B2 (en) | 2014-07-14 | 2017-10-10 | International Business Machines Corporation | Filtration membranes with functionalized star polymers |
US9931598B2 (en) | 2015-02-16 | 2018-04-03 | International Business Machines Corporation | Anti-fouling coatings with star polymers for filtration membranes |
US10005042B2 (en) * | 2015-02-16 | 2018-06-26 | International Business Machines Corporation | Thin film composite forward osmosis membranes with performance enhancing layers |
CN104758981A (en) * | 2015-03-10 | 2015-07-08 | 中山大学 | Growth factor controllable slow-releasing system composite multilayer membrane promoting ossification and preparation method thereof |
CN104911908B (en) * | 2015-05-19 | 2017-01-18 | 武汉纺织大学 | Polyelectrolyte macromolecule nano-membrane-mediated terylene textile normal temperature normal pressure dyeing method |
CN105037785B (en) * | 2015-08-17 | 2019-11-08 | 杭州承前医数科技有限公司 | Polyurethane porous material of compound angiogenic growth factor and preparation method thereof |
CN105582576B (en) * | 2016-02-23 | 2018-08-17 | 武汉大复生物科技有限公司 | Endothelial progenitor cells excretion body is improved to discharge and promote the biomaterial of bone defect healing, Preparation method and use |
CN105714552B (en) * | 2016-04-07 | 2018-01-30 | 中原工学院 | A kind of preparation method of copper sulfide/terylene composite conducting fiber |
CN105714403B (en) * | 2016-04-07 | 2017-09-15 | 中原工学院 | A kind of preparation method of light CuI/PET composite conducting fibers |
CN105714551B (en) * | 2016-04-07 | 2017-12-29 | 中原工学院 | A kind of preparation method of cuprous sulfide/spandex composite conducting fiber |
CN105951419B (en) * | 2016-05-16 | 2017-12-12 | 中国科学技术大学 | A kind of polyester fiber for being crosslinked the modification of LBL self-assembly flame retardant coating and preparation method thereof |
CN106492275A (en) * | 2016-11-11 | 2017-03-15 | 上海市口腔病防治院 | A kind of medicine/factor controlled release membranes support and preparation method thereof |
CN107308501A (en) * | 2017-07-20 | 2017-11-03 | 南开大学 | A kind of method that biological activity protein is loaded on hydrophobic scaffold material and application thereof |
CN107890585B (en) * | 2017-10-31 | 2020-11-10 | 温州医科大学附属第二医院、温州医科大学附属育英儿童医院 | Composite ceramic bracket and preparation method thereof |
ES2953184T3 (en) * | 2018-03-09 | 2023-11-08 | Carmeda Ab | Improvements in immobilization processes of biological entities |
CN108744032A (en) * | 2018-05-15 | 2018-11-06 | 广东医科大学附属医院 | A kind of polyelectrolyte film modified high molecular porous support materials and its preparation method and application |
CN109675106A (en) * | 2018-11-28 | 2019-04-26 | 曲阜师范大学 | A kind of electrospinning fibre bracket of load cells growth factor and preparation method thereof |
CN113403846A (en) * | 2021-07-30 | 2021-09-17 | 南昌大学附属口腔医院(江西省口腔医院) | Polylactic acid nanofiber composite membrane with biomimetic mineralization and antibacterial functions and preparation method and application thereof |
-
2002
- 2002-07-10 CN CN 02112499 patent/CN1193062C/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
CN1394901A (en) | 2003-02-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1193062C (en) | Biological material using electrostatic attraction layer-layer self-assembled modified polyester material as surface with cell compatibility | |
Mingyu et al. | Surface modification and characterization of chitosan film blended with poly-L-lysine | |
CA2236749C (en) | Neuronal stimulation using electrically conducting polymers | |
Feng et al. | The effect of nanofibrous galactosylated chitosan scaffolds on the formation of rat primary hepatocyte aggregates and the maintenance of liver function | |
Gong et al. | Layer-by-layer assembly of chondroitin sulfate and collagen on aminolyzed poly (L-lactic acid) porous scaffolds to enhance their chondrogenesis | |
CN102727931B (en) | Construction and preparation of three-dimensional bionic electropolarized gradient pore nerve conduit | |
Zhu et al. | Endothelial cell functions in vitro cultured on poly (L‐lactic acid) membranes modified with different methods | |
Chiu et al. | Engineering of oriented myocardium on three-dimensional micropatterned collagen-chitosan hydrogel | |
Nwe et al. | Selection of a biopolymer based on attachment, morphology and proliferation of fibroblast NIH/3T3 cells for the development of a biodegradable tissue regeneration template: Alginate, bacterial cellulose and gelatin | |
US7906333B2 (en) | Surface modification of polysaccharide, the modified polysaccharide, and method of culturing and recovery cells using the same | |
He et al. | From waste of marine culture to natural patch in cardiac tissue engineering | |
Li et al. | A novel chitosan hydrogel membrane by an improved electrophoretic deposition and its characteristics in vitro and in vivo | |
JP2013543925A (en) | Method for preparing biocompatible, free-standing, conducting polymer nanofilms | |
CN107149702A (en) | A kind of preparation of poly-dopamine modified lithium porous support | |
Singh et al. | Porous chitosan scaffolds: a systematic study for choice of crosslinker and growth factor incorporation | |
CN102604149B (en) | Three-dimensional chitosan hydrogel and preparation method thereof | |
Perez-Madrigal et al. | Polypyrrole-supported membrane proteins for bio-inspired ion channels | |
CN1233425C (en) | Method for layer-layer self-assembling and fixing biological active factor on tissue engineering material | |
Zhu et al. | The influence of polyelectrolyte charges of polyurethane membrane surface on the growth of human endothelial cells | |
KR20010016051A (en) | Layered air-gap sheet of chitosan and process therefor | |
CN101204592B (en) | Process for fabricating engineering esophagus imitating biochemistry tissue | |
Cassinelli et al. | Physical-chemical and biological characterization of silk fibroin-coated porous membranes for medical applications | |
CN1331923C (en) | Method of modifying polyester material into biological material with cell compatible surface | |
Zhu et al. | Protein electrostatic self‐assembly on poly (DL‐lactide) scaffold to promote osteoblast growth | |
CN109575338B (en) | Polylactic acid composite membrane with surface modified with ordered chitin whisker layer, and preparation method and application thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C19 | Lapse of patent right due to non-payment of the annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |